Evidence map›Paper›PMID 33989754›Full record

ArticleSeminars in thoracic and cardiovascular surgery2022

COVID-19 After Lung Resection in Northern Italy.

Marco Scarci, Federico Raveglia, Luigi Bortolotti, Mauro Benvenuti, Luca Merlo, Lea Petrella, Giuseppe Cardillo, Gaetano Rocco

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Seminars in thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05204537 (The Role of Surgery in Patients With COVID-19 Related Thoracic Complications), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05204537 completednot on this map

The Role of Surgery in Patients With COVID-19 Related Thoracic Complications

TypeobservationalSponsorUniversity of Milano BicoccaRan2020 to 2022Enrolled83ConditionsSurgical Complication, COVID-19, Pneumothorax, Empyema, PleuralArmsLung parenchyma resection, Empyemectomy
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Marco ScarciThoracic Surgery, ASST Monza, Italy. Electronic address: m.scarci@asst-monza.it.
Federico RavegliaThoracic Surgery, ASST Santi Paolo e Carlo, Milan, Italy.
Luigi BortolottiThoracic Surgery, Humanitas Gavazzeni Bergamo, Italy.
Mauro BenvenutiThoracic Surgery, ASST Spedali Civili, Brescia, Italy.
Luca MerloDepartment of Statistical Sciences, Sapienza University of Rome, Italy.
Lea PetrellaMEMOTEF Department, Sapienza University of Rome, Italy.
Giuseppe CardilloThoracic Surgery, San Camillo Forlanini Hospital, Rome, Italy.
Gaetano RoccoThoracic Surgery, Memorial Sloan Kettering, Cornell University, New York.
Sapienza University of Rome · ITAzienda Ospedaliera San Gerardo · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloCarlo Forlanini Hospital · ITHumanitas Gavazzeni · ITMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from patients who underwent lung resection from December 2019 to March 2020 were retrospectively collected until June 2020. Univariable Cox regression models were estimated to evaluate potential prognostic factors for developing COVID-19 and to investigate postoperative mortality among patients who developed symptomatic COVID-19 infection. We examined data from 107 patients. (74 lobectomies, 32 wedge/segmentectomies and 1 pneumonectomy). Twelve patients developed COVID-19 (Group 1), whereas 95 patients were not infected (Group 2). In Group 1, 6 patients (50%) died from complications related to infection; in Group 2, one patient (1%) died because of non-COVID-19-related causes. Median days from surgery to first symptoms, CT confirmation, clinical confirmation and PCR positivity was 48.1, 54.3, 55.1, and 55.2 respectively. At univariable analysis, DLCO/VA% (P = 0.008), duration of the surgery (P = 0.009), smoking history (pack/year) (P < 0.001), BMI (P< 0.001) and number of segments resected (P = 0.010) were associated with COVID-19 onset. Moreover, CCI (P < 0.001), DLCO/VA% (P = 0.002), cigarette pack/year (P < 0.001), BMI (P < 0.001) and COVID-19 (P < 0.001) were associated with death. Patients who undergo lung resection and then develop symptomatic COVID-19 infection are at higher risk of developing severe respiratory complications and postoperative death. Insidious symptoms' onset may lead to a delay in diagnosis. We suggest two mitigating strategies: (1) Improve symptoms surveillance and isolation during recovery period, (2) Be aware of a potential greater risk of developing symptomatic COVID-19 and death correlated with elevated CCI, BMI, smoking history, DLCO/VA%, number of resected segments and duration of surgery.

Indexed as

COVID-19Lung NeoplasmsHumansItalyLungPandemicsRetrospective StudiesTreatment OutcomeCOVID-19Lung resectionNorthern ItalyThoracic surgery

Identifiers

PMID33989754
PMCPMC8111882
OpenAlexW3161940820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.